ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,458,673, issued on Nov. 4, was assigned to University of Pittsburgh-Of the Commonwealth System of Higher Education (Pittsburgh).
"Use of specific phages for the treatment of nontuberculosis mycobacteria (NTM) infections" was invented by Graham F. Hatfull (Pittsburgh), Carlos Andres Guerrero (Pittsburgh) and Rebekah Marie Dedrick (Glenshaw, Pa.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are compositions comprising bacteriophages and methods of using these compositions for treating NTM infections. The present disclosure also provides compositions for screening bacteriophages that are effective in treating NTM infections and methods of ...